These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 29363047)

  • 1. New perspectives on the definition and management of polycystic ovary syndrome.
    Pasquali R; Gambineri A
    J Endocrinol Invest; 2018 Oct; 41(10):1123-1135. PubMed ID: 29363047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
    Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
    Spritzer PM; Motta AB
    Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The latest reports and treatment methods on polycystic ovary syndrome.
    Stańczak NA; Grywalska E; Dudzińska E
    Ann Med; 2024 Dec; 56(1):2357737. PubMed ID: 38965663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and challenges of polycystic ovary syndrome in adolescence.
    Agapova SE; Cameo T; Sopher AB; Oberfield SE
    Semin Reprod Med; 2014 May; 32(3):194-201. PubMed ID: 24715514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Female Pelvic Conditions: Polycystic Ovary Syndrome.
    Wilkinson LD; Brady PH; Gin GT; Rosenblum E
    FP Essent; 2022 Apr; 515():26-31. PubMed ID: 35420404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild androgen phenotypes.
    Carmina E
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):207-20. PubMed ID: 16772152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and acne.
    Chuan SS; Chang RJ
    Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
    Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the treatment of polycystic ovary syndrome.
    Yildiz BO
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1295-305. PubMed ID: 15461558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best methods for identification and treatment of PCOS.
    Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
    Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.